Ovid Therapeutics Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Ovid Therapeutics Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2016 to Q3 2024.
  • Ovid Therapeutics Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $182K, a 26.8% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $182K -$66.7K -26.8% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $246K -$44K -15.2% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $174K -$38.5K -18.1% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $210K -$51.2K -19.6% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $249K -$26.8K -9.73% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $290K -$38.8K -11.8% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $213K -$31.5K -12.9% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $261K +$1.07K +0.41% Dec 31, 2022 10-K 2024-03-08
Q3 2022 $275K +$78.3K +39.7% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $329K +$101K +44.6% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $244K -$18.8K -7.14% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $260K -$58.8K -18.4% Dec 31, 2021 10-K 2023-03-13
Q3 2021 $197K -$164K -45.4% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $227K -$148K -39.5% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $263K -$173K -39.8% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $319K -$148K -31.7% Dec 31, 2020 10-K 2022-03-15
Q3 2020 $361K +$9.69K +2.76% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $376K +$105K +38.7% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $436K +$105K +31.8% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $467K +$75.4K +19.2% Dec 31, 2019 10-K 2021-03-15
Q3 2019 $351K -$54.8K -13.5% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $271K -$42.4K -13.5% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $331K +$171K +106% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $392K +$268K +216% Dec 31, 2018 10-K 2020-03-11
Q3 2018 $406K +$198K +95.5% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $313K +$97.6K +45.2% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $160K -$39.9K -19.9% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $124K -$41.1K -24.9% Dec 31, 2017 10-K 2019-03-07
Q3 2017 $208K Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $216K Jun 30, 2017 10-Q 2017-08-10
Q1 2017 $200K Mar 31, 2017 10-Q 2017-06-13
Q4 2016 $165K Dec 31, 2016 10-K 2018-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.